[HTML] mdpi.com

[HTML][HTML] Noradrenaline and movement initiation disorders in Parkinson's disease: a pharmacological functional MRI Study with clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - mdpi.com
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …
被引用次数：7 相关文章

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - hal.science
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine.

M Criaud, C Laurencin, A Poisson… - Cells (2073 …, 2022 - search.ebscohost.com
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …
[PDF] kcl.ac.uk

[PDF][PDF] Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine. Cells 2022, 11, 2640

M Criaud, C Laurencin, A Poisson, E Metereau… - 2022 - kclpure.kcl.ac.uk
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - univ-lyon1.hal.science
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - search.proquest.com
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - 2022 - pubmed.ncbi.nlm.nih.gov
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - hal.in2p3.fr
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - 2022 - agris.fao.org
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …
[HTML] nih.gov

[HTML][HTML] Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine

M Criaud, C Laurencin, A Poisson, E Metereau… - Cells, 2022 - ncbi.nlm.nih.gov
Slowness of movement initiation is a cardinal motor feature of Parkinson's disease (PD) and
is not fully reverted by current dopaminergic treatments. This trouble could be due to the …